Clinical Trial Results:
A Multicenter, Randomized Double-Blind Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Mild to Moderate Alzheimer's Disease.
Revised Protocol 04, incorporating Administrative Letters 01 & 02, Protocol Amendment 02 (v1.0, dated 02-Feb-2009), Amendment 03 (v1.0, dated 27-Mar-2009), Amendment 04 (v1.0, dated 03-Sep-2009) and Amendment 05 (v1.0, dated 18-Feb-2010). And Pharmacogenetics Blood Sample Amendment 01 - Site Specific (v1.0, dated 14-Nov-2008)
Summary
|
|
EudraCT number |
2008-005929-11 |
Trial protocol |
SE FI DK |
Global completion date |
07 Jun 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CN156-013_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.